Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05571397 · ClinicalTrials.gov registry record · Phase 1
Expanding Use of CGM in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes
A Phase 1 study of Hyperglycemia, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 201
- Enrollment target
- 1
- Study location
NCT05571397: Completed Phase 1 study of Hyperglycemia, sponsored by Ohio State University.
NCT05571397 is a Phase 1 study of Hyperglycemia that has completed, run by Ohio State University. The registered enrollment target is 201 participants, below the 874-participant average among 38 other Hyperglycemia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05571397, a Phase 1 study of Hyperglycemia, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 201 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this implementation study is to assess the feasibility of real time continuous glucose monitoring (CGM) implementation using a CGM plus (+) point-of-care (POC) protocol among patients on IV insulin or those with hyperglycemia (\>250mg/dl) in the critical care hospital environments.
Primary Outcome
Percent of time in target glycemic ranges: 100-180 mg/dl, 70-180mg/dl, 140-180mg/d
Conditions Studied
Interventions
- DEVICE Dexcom G6
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2024-09-19 |
| Phase | Phase 1 |
What the finished NCT05571397 record still lists
NCT05571397 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 874-participant average among 38 other Hyperglycemia trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Hyperglycemia appearing as the primary indexed condition, and to 1 intervention - of which Dexcom G6 is the first listed.
NCT05571397 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05571397 about?
NCT05571397 is a clinical study titled "Expanding Use of CGM in Critical Care: Impact on Nurse Work Patterns and Patient Outcomes". The primary objective of this implementation study is to assess the feasibility of real time continuous glucose monitoring (CGM) implementation using a CGM plus (+) point-of-care (POC) protocol among patients on IV insulin or those with hyperglycemia (\>250mg/dl) in the critical care hospital enviro...
What is the current status of trial NCT05571397?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 201 participants. The study started on 2023-11-01. Estimated completion is 2024-09-19.
What conditions does trial NCT05571397 study?
This clinical trial studies the following conditions: Hyperglycemia.
What interventions are being tested in trial NCT05571397?
The interventions under investigation include: Dexcom G6 (DEVICE).
Who is sponsoring clinical trial NCT05571397?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05571397 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05571397's enrollment target sits among peer trials
201 9th of 38 higher than 30 of 38 other Hyperglycemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hyperglycemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Insulin Balanced Infusion System
ACTIVE NOT RECRUITING · Phase 1
-
GLP 1 for Intraoperative Glycemic Control
COMPLETED · Phase 1
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04422652 · 201 participants · Phase 2
Combination of Novel Therapies for CKD Comorbid Depression
- NCT05327114 · 201 participants · Phase 2
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- NCT06099769 · 201 participants · Phase 2
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
- NCT06274528 · 201 participants · Phase 2
DORA and LP in Alzheimer's Disease Biomarkers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI